Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis
✍ Scribed by A. J. Whittle; O. A. Ross; A. Naini; P. Gordon; H. Mistumoto; J. C. Dächsel; J. T. Stone; Z. K. Wszolek; M. J. Farrer; S. Przedborski
- Book ID
- 106207025
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 90 KB
- Volume
- 114
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To elucidate the role of cyclooxygenase‐1 (Cox1) and prostaglandin E~2~ in ALS neurodegeneration. ## Methods Mutation in superoxide dismutase‐1 is a cause of the fatal paralytic disorder amyotrophic lateral sclerosis. Inhibition of cyclooxygenase‐2 (Cox‐2) in transgenic
The concept of paraneoplastic disease, a "remote" nonmetastatic effect of cancer, was brought to clinical neurology by Lord Brain in the 1950s. 1 had just begun my own career in neurology and I remember well how From the